SHIPPING OFF DIABETES
Researchers have identified a gene that could predispose people to adult-onset or ‘type II’ diabetes (Nature, Vol. 409, No. 6816, 04 Jan 2001). The gene, SHIP2, is also a potential therapeutic target for the treatment of this non-insulin-dependent type of diabetes, which is on the increase in the developing world. Stephane Schurmans of IRIBHN, Gosselies, Belgium, and colleagues have engineered mice lacking SHIP2; these mice show that the gene is a critical and essential down-regulator of insulin signalling and insulin sensitivity. CONTACT: Stephane Schurmans tel +32 2 650 98 21 fax +32 2 650 98 20 e-mail sschurma@ulb.ac.be (C) Nature press release.
Message posted by: Trevor M. D'Souza
|